SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001385508-18-000108
Filing Date
2018-11-07
Accepted
2018-11-07 16:06:52
Documents
61
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q opnt0930201810q.htm 10-Q 754280
2 EXHIBIT 31.1 exhibit31109302018.htm EX-31.1 12654
3 EXHIBIT 31.2 exhibit31209302018.htm EX-31.2 12633
4 EXHIBIT 32.1 exhibit32109302018.htm EX-32.1 5816
5 EXHIBIT 32.2 exhibit32209302018.htm EX-32.2 5578
  Complete submission text file 0001385508-18-000108.txt   4588571

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT opnt-20180930.xml EX-101.INS 679990
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opnt-20180930.xsd EX-101.SCH 54014
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opnt-20180930_cal.xml EX-101.CAL 46141
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opnt-20180930_def.xml EX-101.DEF 285902
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opnt-20180930_lab.xml EX-101.LAB 586407
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opnt-20180930_pre.xml EX-101.PRE 384057
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38193 | Film No.: 181166331
SIC: 1000 Metal Mining
Assistant Director 9